The majority of patients with psoriatic arthritis are not eligible for randomised clinical trials. [electronic resource]
Producer: 20190306Description: 1068-1073 p. digitalISSN:- 0392-856X
- Adult
- Antirheumatic Agents -- adverse effects
- Arthritis, Psoriatic -- diagnosis
- Biological Products -- adverse effects
- Databases, Factual
- Eligibility Determination -- methods
- Female
- Humans
- Iceland
- Male
- Middle Aged
- Patient Selection
- Randomized Controlled Trials as Topic -- methods
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.